Which proton pump inhibitor (PPI) should be given to a patient with melena, and what is the first workup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

PPI Selection and Initial Workup for Melena

Start high-dose intravenous PPI therapy immediately—either omeprazole or pantoprazole 80 mg IV bolus followed by 8 mg/hour continuous infusion for 72 hours—while arranging urgent upper endoscopy within 24 hours. 1

Which PPI to Give

Any PPI is acceptable as this is a class effect, but the evidence specifically supports:

  • Omeprazole 80 mg IV bolus → 8 mg/hour infusion × 72 hours 1
  • Pantoprazole 80 mg IV bolus → 8 mg/hour infusion × 72 hours 1

The specific dosing regimen matters more than which PPI you choose. High-dose therapy (80 mg bolus + continuous infusion) reduces rebleeding, need for surgery, and mortality in high-risk patients 1.

Route of administration: Use IV for patients presenting with melena (presumed high-risk), though oral high-dose PPI (40 mg twice daily) can be considered for lower-risk patients 1.

First Workup

Immediate Assessment (Before Endoscopy)

  1. Hemodynamic status: Vital signs, orthostatics, signs of shock
  2. Complete blood count: Hemoglobin/hematocrit for transfusion decisions
  3. Coagulation studies: PT/INR, aPTT if on anticoagulants
  4. Type and crossmatch: Prepare for potential transfusion
  5. Basic metabolic panel: Assess for uremia (elevated BUN:creatinine ratio suggests upper GI source)
  6. Glasgow-Blatchford Score: Calculate to stratify risk (score ≤1 = very low risk, may not require hospitalization) 2, 3

Key Clinical Details to Elicit

  • Medication history: NSAIDs, aspirin, anticoagulants, antiplatelet agents, corticosteroids
  • Prior GI bleeding: Single strongest risk factor for recurrence 4
  • Comorbidities: Cardiovascular disease (affects transfusion threshold), liver disease
  • Symptoms: Hematemesis, syncope, ongoing melena volume

Transfusion Threshold

  • Hemoglobin <80 g/L for patients without cardiovascular disease
  • Higher threshold for those with cardiovascular disease 2

Timing of Endoscopy

Perform upper endoscopy within 24 hours (not urgent <12 hours unless unstable) 2, 3. Early endoscopy (≤24 hours) improves outcomes; urgent endoscopy (<12 hours) does not provide additional benefit 3.

Post-Endoscopy Management

After endoscopy, adjust therapy based on findings:

  • High-risk stigmata (active bleeding, visible vessel, adherent clot): Continue high-dose IV PPI for 72 hours, then switch to oral PPI 40 mg twice daily for 14 days, then once daily 2
  • Low-risk stigmata (clean base, flat spot): Can feed within 24 hours and consider early discharge 1
  • Test for H. pylori: All patients with ulcers should be tested and treated if positive—this is critical for preventing rebleeding 1

Common Pitfalls

  • Don't delay endoscopy for PPI therapy: Start PPI immediately but don't postpone endoscopy—PPI is not a replacement for endoscopic hemostasis 1
  • Don't stop aspirin: If patient is on low-dose aspirin for secondary cardiovascular prophylaxis, continue it or restart within 3-5 days 3
  • Don't use standard-dose PPI: The 80 mg bolus + 8 mg/hour infusion regimen is specifically validated; lower doses may be suboptimal 1
  • Don't forget H. pylori testing: This is a strong recommendation (Grade A) that significantly reduces ulcer recurrence 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.